RA Capital Management, LLC, 10% Owner at ACHILLION PHARMACEUTICALS INC (ACHN), sold 835,293 shares at $11.41 ($9.7M) on 2014-08-29, disclosed to the SEC on 2014-09-02.
Open-market sale of $9.7M ACHN by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.51 | 173,641 | $2.0M | 20.6% |
| 2 | $11.40 | 217,000 | $2.5M | 25.5% |
| 3 | $11.41 | 64,000 | $730K | 7.5% |
| 4 | $11.41 | 33,960 | $387K | 4.0% |
| 5 | $11.42 | 2,635 | $30K | 0.3% |
| 6 | $11.44 | 30,500 |
| $349K |
| 3.6% |
| 7 | $11.45 | 46,600 | $534K | 5.5% |
| 8 | $11.53 | 4,150 | $48K | 0.5% |
| 9 | $11.93 | 1,100 | $13K | 0.1% |
| 10 | $12.01 | 103,052 | $1.2M | 12.7% |
| 11 | $12.04 | 158,655 | $1.9M | 19.7% |
| Total | $11.63 avg | 835,293 | $9.7M | 100% |
| Filing → |
| KALA | BUY | 2018-10-05 | $40.0M | — | Filing → |
| ARVN | BUY | 2018-10-03 | $16.0M | — | Filing → |
| WVE | BUY | 2017-11-15 | $9.9M | — | Filing → |